Rociverine

DB13581InvestigationalSmall molecule

Rociverine is an antispasmodic indicated in the treatment of urinary, gastrointestinal, and biliary tract spasms. A medication used to treat spasms in the urinary and digestive tract.

Chemical structure of Rociverine
Mechanism
Curator reviewed
Formula / weight
C20H37NO3 · 339.52 g/mol (avg)

Resolves to

Compound
UNIIVI08KS44V0CAS53716-44-2ChEBI135440
Clinical / RWD
ATCA03AA06
Structure
InChIKeyXPYLKZZOBVLVHB-QDKIRNHSSA-NSMILESCCN(CC)CC(C)OC(=O)[C@H]1CCCC[C@]1(O)C1CCCCC1
Targets
P11229CHRM1P08172CHRM2P20309CHRM3P08173CHRM4P08912CHRM5

What you can answer from here — as of March 06, 2025

5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
516Drug interactionsStructured to mechanism, not free text
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
6ContraindicationsEach with its own population and attribute set
Sign in
8Marketed productsAcross 2 countries and 4 labellers
Sign in
1ATC codeIncluding every combination product, plus 12 drug categories
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Rociverine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In